Continental’s Aumovio eyes 22% sales boost ahead of September IPO
Aumovio, Continental’s soon-to-be independent automotive company, is aiming for a 22% long-term sales gain as it prepares to go public...
How billionaire Caltagirone could influence Italy’s banking M&A wave
MILAN (Reuters) -Italian billionaire Francesco Gaetano Caltagirone has emerged as a leading player in the reshaping of Italy’s financial sector...
XRP drops to $2 as geopolitical tensions fuel 11% weekly slide
Ripple’s XRP has slipped below the $2.00 threshold for the first time in nearly three months, signalling growing unease across...
AMD stock price forecast as a ‘mini’ golden cross forms
AMD stock price has bounced back in the past few months, mirroring the performance of most companies, which have soared...
HIMS stock plunges as Novo Nordisk severs ties with Hims & Hers over Wegovy sales
Novo Nordisk A/S has abruptly terminated its partnership with Hims & Hers Health Inc., just weeks after it was announced,...
US stocks shrug off Mideast tensions: Dow Jones, S&P trade flat
Stocks were little changed on Monday despite the United States joining Israel’s military campaign against Iran over the weekend with...
JP Morgan initiates coverage on Marriott, sees 9% upside
JP Morgan initiated coverage on Marriott International. The brokerage sees a 9% upside on the hotel company.Balanced risk profileThe brokerage...
Tesla’s $4.20 robotaxi ride revives AI bull case, but analysts warn of long road ahead
Tesla Inc. made a modest but pivotal move in its bid to dominate the autonomous vehicle industry by launching its...
UK industrial strategy targets energy costs, R&D and finance access to spur growth
The UK government has unveiled a sweeping new industrial strategy aimed at revitalising the British economy through targeted investment, innovation,...
Compass Pathways stock slip as psilocybin depression trial falls short of expectations
Shares of Compass Pathways Plc plunged as much as 37% during pre-market trading on Monday after the company’s experimental psilocybin...
